SourcingAI
Try for free
Powered by Made-in-China.com
GMP Certified High Quality Ceftriaxone Sodium for Injection 0.5g
US$1.00
10,000-99,999 Pieces
US$0.10
100,000+ Pieces

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

for Injection

Model NO.

0.25g, 0.5g, 1.0g

Suitable for

Elderly, Children, Adult

State

Solid

Shape

Powder

Type

Organic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Transport Package

1vial/Box; 10vials/Box; 50vials/Box

Specification

0.25g, 0.5g, 1.0g

Trademark

Reyoung

Origin

China Reyoung

Production Capacity

50million Vials/Year

Key features

GMP Certified Quality: Manufactured under strict GMP standards with ISO9001 and ISO14001 certifications.
Broad Clinical Application: Treats respiratory, urinary, abdominal, skin, bone infections, sepsis, and meningitis.
Massive Production Capacity: Annual output of 2.5 billion vials of powder for injection and 4 billion tablets.
Global Market Coverage: Products exported to over 70 countries across Asia, Europe, Africa, and South America.
OEM and ODM Services: Customized manufacturing services available for international partners.
Advanced Manufacturing Facilities: Three main factories covering 1,000,000 square meters with 30 workshops.
Experienced International Team: Over 20 years of experience in international transactions and documentation.
Multi-Country GMP Compliance: Passed GMP inspections in Colombia, Peru, Nigeria, Kenya, Pakistan, and more.

Company profile

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2020-10-13 CertifiedNearest Port: Qingdao PortAverage Response Time: ≤24h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryReyoung Pharmaceutical Co., Ltd. is a Chinese pharmaceutical manufacturer established in 1998, with a significant workforce of 4950 employees and a substantial registered capital. The company holds important certifications like ISO9001:2015, and its production includes a broad range of products such as injectables and antibiotics. Reyoung has been engaged in export since 2020, with exports accounting for 31% to 40% of their sales. They have a strong production capability, operating over ten production lines with an annual output exceeding $100 million. Despite limited information on financial credibility and innovation capability, their comprehensive certifications and extensive history suggest robustness in these areas.
Supplier typeReyoung Pharmaceutical Co., Ltd. is a limited company based in Shandong, China, operating as a combined business entity.
CertificationsThe supplier holds ISO9001:2015, ISO14001:2015, ISO45001:2016 certifications, and complies with cGMP, PIC/S, and ANVISA GMP standards.
Production capacityWith over 10 production lines and a wide range of pharmaceutical products, Reyoung demonstrates strong production capability.
Client casesThe supplier has conducted transactions with international clients like HEREDIA ARACENA RENY EVELIN and STERILE INDIA PRIVATE LIMITED.

Product Q&A

Q:What are the main applications of Ceftriaxone Sodium for Injection?
A:
It is used for lower respiratory tract, urinary tract, biliary tract, abdominal, pelvic, skin, soft tissue, bone, and joint infections, as well as sepsis, meningitis, and operation period infection prevention. It can also treat uncomplicated gonorrhea.
Q:What certifications does Reyoung Pharma hold?
A:
Reyoung Pharma is a GMP, ISO9001, ISO14001, and OHS18001 authenticated enterprise. It is also a state-focused high & new tech enterprise and has passed GMP inspections in numerous countries including Colombia, Peru, and Nigeria.
Q:What is the annual production capacity of the manufacturer?
A:
The annual production capacity includes 2.5 billion vials of powder for injection, 300 million ampoules of liquid injection, 4 billion tablets, 6 billion capsules, 200 million bags of granules, and 2000 tons of API.
Q:Does the company offer OEM or ODM services?
A:
Yes, OEM Service and ODM Service are available for international clients.
Q:What are the payment terms and lead times?
A:
Terms of payment include LC, T/T, and D/P. The average lead time is 1-3 months for both peak season and off-season.

Send Inquiry

*To:Reyoung Pharmaceutical Co., Ltd.Reyoung Pharmaceutical Co., Ltd.
*Content:
0/4000

Supplier replies will be sent to your registered email

You may also like